A substance derived from hashish can be especially effective as an anti-inflammatory drug for treating rheumatoid arthritis, a doctoral student at the Hebrew University of Jerusalem maintains. For her work with hashish as a therapeutic agent, Susanna Tchilibon, a 32-year-old immigrant from Milan, was been named a winner of this year’s Kaye Prizes for Innovations and Inventions at the university.
Help ensure Jewish news remains accessible to all. Your donation to the Jewish Telegraphic Agency powers the trusted journalism that has connected Jewish communities worldwide for more than 100 years. With your help, JTA can continue to deliver vital news and insights. Donate today.
The Archive of the Jewish Telegraphic Agency includes articles published from 1923 to 2008. Archive stories reflect the journalistic standards and practices of the time they were published.
